相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Rapamycin: A bone sparing immunosuppressant?
David F. Romero et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
PTH-analogs: Comparable or different?
H.J.J. Verhaar et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2009)
Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice
Toshihiro Sugiyama et al.
BONE (2008)
Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells
Ujjal K. Singha et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions
Liza J. Raggatt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone
Yongmei Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
MTOR, translation initiation and cancer
Y. Mamane et al.
ONCOGENE (2006)
The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment
Kimihiko Sawakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanical stimuli and nutrients regulate rapamycin-sensitive signaling through distinct mechanisms in skeletal muscle
TA Hornberger et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice
M Yamaguchi et al.
ENDOCRINOLOGY (2005)
Sirolimus for Kaposi's sarcoma in renal-transplant recipients
G Stallone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Antileukemic activity of rapamycin in acute myeloid leukemia
C Récher et al.
BLOOD (2005)
Drug therapy in the heart transplant recipient - Part II: Immunosuppressive drugs
J Lindenfeld et al.
CIRCULATION (2004)
Drug-eluting stents
TC Woods et al.
ANNUAL REVIEW OF MEDICINE (2004)
Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone
RM Locklin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone
DD Bikle et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control
R Loewith et al.
MOLECULAR CELL (2002)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Immunosuppressant use without bone loss - Implications for bone loss after transplantation
GR Goodman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
BD Kahan
LANCET (2000)
分享论文
